Skip to main content

Table 2 Demographic and disease-specific findings for entire cohort and individual study groups

From: Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study

Variable Entire cohort (n = 71) Normal-Mild (n = 58) Moderate-Severe (n = 13) P-value
Average age 59.7 60.4 59.7 0.79
Gender
Males 50 (70.4 %) 46 (79.3 %) 8 (61.5 %) 0.65
Females 21 (29.6 %) 12 (20.7 %) 5 (38.5 %) 0.51
TNM staging
Early 7 (9.9 %) 12 (20.7 %) 3 (23.1 %) 0.35
Advanced 64 (90.1 %) 46 (79.3 %) 10 (76.9 %) 0.32
Site
Oral Cavity/Oropharynx 39 (54.9 %) 29 (50.0 %) 10 (76.9 %) 0.07
Larynx 9 (12.7 %) 9 (15.5 %) 0 (0.0 %) 0.11
Other 23 (32.4 %) 20 (34.5 %) 3 (23.1 %) 0.32
Reconstruction
Osseocutaneous FF 11 (15.5 %) 9 (15.5 %) 2 (15.4 %) 1.00
Fasciocutaneous FF 58 (81.7 %) 48 (82.8 %) 10 (76.9 %) 0.24
Pedicled/Rotational 2 (2.8 %) 1 (1.7 %) 1 (7.7 %) 0.35
Adjuvant therapy
Radiation therapy (RT) 57 (80.3 %) 46 (79.3 %) 11 (84.6 %) 0.56
Chemotherapy (C) 32 (45.1 %) 26 (44.8 %) 6 (46.2 %) 0.22
Chemoradiation Therapy (CRT) 32 (45.1 %) 26 (44.8 %) 6 (46.2 %) 0.22
Pre-treatment substance abuse 16 (22.5 %) 15 (25.9 %) 1 (7.7 %) 0.82
Supports/Caregivers available 61 (85.9 %) 48 (82.8 %) 11 (84.6 %) 0.81
Charlson comorbidity index Mean 70.2 %, Median 77 % Mean 70.2 %, Median 77 % Mean 70.2 %, Median 90 % 0.65
  1. FF free flap, RT radiation therapy, CRT chemoradiation therapy, C chemotherapy